BIO-B
#7584
Bio-Rad Laboratories, Inc. Class B Common Stock
296.4 9 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.24%
Monthly Change
+2.24%
6 month change
+10.26%
Year Change
+4.45%
Previous Close
290.0 0
Open
291.9 9
Low
291.9 9
High
296.4 9
Volume
2
Financials
- Market Capitalization 8.75 B
- Employee 7 450
- Founded N/A
- CEO Norman David Schwartz
- Website www.bio-rad.com
- Headquarter Delaware, United States
- FIGI BBG000DY28W5
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 7425 |  OSRHW OSR Holdings, Inc. - Warrant | 0.0430 USD | -9.09% | -10.23% | -23.08% | -13.13% | 16.15 M USD | ||
| 7450 |  HSCSW HeartSciences Inc. - Warrant | 0.0385 USD | 0.00% | -23.00% | -23.61% | -67.92% | 7.88 M USD | ||
| 7486 |  TNONW Tenon Medical, Inc. - Warrant | 0.0081 USD | 0.00% | 0.00% | -5.81% | -56.22% | 2.20 M USD | ||
| 7489 |  BBLGW Bone Biologics Corp - warrants | 8.0000 USD | 0.00% | 0.00% | -27.27% | -26.27% | 1.71 M USD |
Frequently asked questions about Bio-Rad Laboratories, Inc. Class B Common Stock
What is the Bio-Rad Laboratories, Inc. Class B Common Stock stock price today?
The current price of Bio-Rad Laboratories, Inc. Class B Common Stock (BIO-B) is 296.49. Over the past 24 hours, the stock has changed by +2.24%. Follow the BIO-B chart for real-time price dynamics.
What is the stock ticker of Bio-Rad Laboratories, Inc. Class B Common Stock?
Bio-Rad Laboratories, Inc. Class B Common Stock trades under the ticker BIO-B. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bio-Rad Laboratories, Inc. Class B Common Stock stock going up?
BIO-B has changed by +2.24% over the last week, +2.24% over the last month, and +4.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bio-Rad Laboratories, Inc. Class B Common Stock?
Bio-Rad Laboratories, Inc. Class B Common Stock currently has a market capitalization of 8.75 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Bio-Rad Laboratories, Inc. Class B Common Stock earnings last quarter?
Last quarter, Bio-Rad Laboratories, Inc. Class B Common Stock reported earnings of -19.55 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Bio-Rad Laboratories, Inc. Class B Common Stock revenue for the last quarter?
Bio-Rad Laboratories, Inc. Class B Common Stock reported quarterly revenue of 592.1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Bio-Rad Laboratories, Inc. Class B Common Stock net income for the last quarter?
Bio-Rad Laboratories, Inc. Class B Common Stock reported net income of -527.1 M for the last quarter. The previous quarter showed 720 M, which means net income changed by -173.21%.
How many employees does Bio-Rad Laboratories, Inc. Class B Common Stock have?
As of the latest available data, Bio-Rad Laboratories, Inc. Class B Common Stock has 7 450 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bio-Rad Laboratories, Inc. Class B Common Stock EBITDA?
Bio-Rad Laboratories, Inc. Class B Common Stock EBITDA is 34.1 M, and its EBITDA margin is 5.76%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bio-Rad Laboratories, Inc. Class B Common Stock stock?
You can buy Bio-Rad Laboratories, Inc. Class B Common Stock (BIO-B) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bio-Rad Laboratories, Inc. Class B Common Stock stock?
Investing in Bio-Rad Laboratories, Inc. Class B Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIO-B chart and related analysis on metatrader.com as part of your research.